Additionally, it has been reported that tau CSF levels can increase in normal aging and can fail to discriminate AD from other forms of dementia like vascular dementia (VaD), frontotemporal dementia (FTD), and Creutzfeldt–Jakob disease (CJD) [48,49]. This evidence concerns the gene MAPT and Alzheimer disease.